Ifp Advisors, Inc Annovis Bio, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$10.26 - $21.81 $41,040 - $87,240	4,000 Added 666.67%	4,600 $44,000
Q2 2022 Sep 06, 2022	BUY	$8.61 - $13.87 $5,166 - $8,322	600 New	600 $6,000
Q2 2022 Aug 12, 2022	SELL	$8.61 - $13.87 $5,166 - $8,322	-600 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$11.84 - $19.78 $7,104 - $11,868	600 New	600 $8,000

1.2M

779K

1.77M

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $45.4M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.